GLYEX Trademark

Trademark Overview

On Tuesday, April 21, 2020, a trademark application was filed for GLYEX with the United States Patent and Trademark Office. The USPTO has given the GLYEX trademark a serial number of 88880762. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, September 7, 2023. This trademark is owned by Moleculin Biotech, Inc.. The GLYEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and products for treatment of COVID-19
glyex

General Information

Serial Number88880762
Word MarkGLYEX
Filing DateTuesday, April 21, 2020
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, September 7, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 20, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and products for treatment of COVID-19

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 30, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMoleculin Biotech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHouston, TX 77007
Party NameMoleculin Biotech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77007

Trademark Events

Event DateEvent Description
Saturday, September 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 7, 2023SOU EXTENSION 4 GRANTED
Thursday, September 7, 2023SOU EXTENSION 4 FILED
Thursday, September 7, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 8, 2023SOU EXTENSION 3 GRANTED
Wednesday, March 8, 2023SOU EXTENSION 3 FILED
Wednesday, March 8, 2023SOU TEAS EXTENSION RECEIVED
Friday, December 16, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 16, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 16, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 7, 2022SOU EXTENSION 2 GRANTED
Wednesday, September 7, 2022SOU EXTENSION 2 FILED
Wednesday, September 7, 2022SOU TEAS EXTENSION RECEIVED
Saturday, March 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 10, 2022SOU EXTENSION 1 GRANTED
Thursday, March 10, 2022SOU EXTENSION 1 FILED
Thursday, March 10, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 1, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 1, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 1, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 20, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 30, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 11, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 29, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 28, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 28, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 28, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, April 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 28, 2020NON-FINAL ACTION E-MAILED
Wednesday, October 28, 2020NON-FINAL ACTION WRITTEN
Tuesday, October 20, 2020ASSIGNED TO EXAMINER
Thursday, April 30, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 24, 2020NEW APPLICATION ENTERED

Related Keywords

glyex covid treatment products preparations pharmaceutical